Stock Information

Markets
TSX21357.56+64.60
TSXV902.99-4.05
DOW35911.81-201.81
S&P 5004662.85+3.82
NASD14893.75+86.94
ASX7393.90-80.50
Commodities
Gold1817.43+0.73
Silver22.96+0.03
Copper4.43-0.12
Palladium1880.14+11.13
Platinum973.64+2.64
Oil84.27+2.15
Heating Oil2.59-0.02
Natural Gas4.23-0.04
Currencies
BTCUSD43032.58+18.02
USDCAD1.2547+0.0002
USDEUR0.87600.0000
USDGBP0.7312+0.0001
USDAUD1.3882-0.0039
USDJPY114.22-0.01

Pall Corporation's new Supralon Filter Element Advances Equipment Protection and Reduces Energy Costs

- Pall Corporation, a leader in filtration, separation and purification technology and a Danaher operating company, launched the new Supralon TM hydraulic and lube oil filter element range, a direct upgrade for Pall's Coralon ® Ultipor ® and Red1000 series filters. Supralon filter elements incorporate a new pack construction with filter media utilizing stress-resistant technology (SRT) and showcasing anti-static properties, which ultimately help protect and prolong the life of equipment in hydraulic and lube oil applications.

Keep reading... Show less

DANAHER SCHEDULES FOURTH QUARTER 2021 EARNINGS CONFERENCE CALL

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2021 on Thursday, January 27, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour.

The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com , under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.

Keep reading... Show less

IDBS Polar Insight Brings Advanced Data Analytics and Visualization to BioPharma Lifecycle Management

IDBS, a Danaher (NYSE:DHR) operating company, announced Polar Insight, bringing new advanced data analytics and visualization tools to the Polar BioPharma Lifecycle Management (BPLM) platform.

Extracting valuable insights from process and quality data across the biopharmaceutical lifecycle is a time consuming and error prone process, requiring laborious manual work and multiple steps.

Keep reading... Show less
×